跳至主要内容
临床试验/NCT03417492
NCT03417492终止1 期

Cerebrovascular Reactivity Assessed With Functional Near-infrared Spectroscopy and Magnetic Resonance Imaging as a Biomarker of Traumatic Microvascular Injury in American Football Players

University of Pennsylvania1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2018年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
终止
入组人数
7
试验地点
1
主要终点
Effect of single dose sildenafil citrate treatment on global blood oxygen level-dependent (BOLD) response to hypercapnia.

研究概览

简要总结

Investigators will measure cerebrovascular reactivity (CVR) using functional near-infrared spectroscopy (fNIRS) and magnetic resonance imaging (MRI) during the chronic phase after repetitive mild traumatic brain injury (rmTBI) as a biomarker of traumatic cerebrovascular injury (TCVI). We hypothesize that CVR will be decreased in patients with rmTBI and that these decreases will correlate with clinical outcomes. Furthermore, we predict that 5 week administration of a phosphodiesterase 5 (PDE5) inhibitor, sildenafil citrate, will augment CVR in patients with a history rmTBI.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age 40-65 years
  • Former National Football League (NFL) players or former varsity college football players
  • Ability to undergo MRI scanning
  • Ability to read, write, and speak English
  • Stable doses of concomitant medications for last 2 weeks prior to enrollment
  • Diagnosis of post-concussive syndrome according to Diagnostic and Statistical Manual 5 (DSM-5) criteria

排除标准

  • Contraindication to sildenafil
  • Past medical history or evidence of penetrating brain injury
  • Daily therapy with a PDE5 inhibitor within the past 2 months, or taken as needed within past 4 weeks
  • History or evidence of pre-existing disabling neurological or psychiatric disorder not related to previous head injuries
  • History of melanoma
  • History of diagnosed obstructive/ restrictive pulmonary disease 7 .) Contraindication to MRI

研究组 & 干预措施

Sildenafil Citrate

Experimental

Open label treatment with forced titration of sildenafil citrate.

干预措施: Sildenafil Citrate (Drug)

结局指标

主要结局

Effect of single dose sildenafil citrate treatment on global blood oxygen level-dependent (BOLD) response to hypercapnia.

时间窗: Immediate

Determine if single dose treatment with sildenafil (60 mg orally) is effective in increasing the global BOLD response to hypercapnia (5% CO2).

次要结局

  • Effect of single dose sildenafil citrate treatment on functional near-infrared spectroscopy (fNIRS) response to hypercapnia.(Immediate)
  • Maximum tolerable dose of sildenafil therapy without severe adverse events.(5 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ramon Diaz-Arrastia

Presidential Professor

University of Pennsylvania

研究点 (1)

Loading locations...

相似试验